To address the challenge of controlling protein activation in living animals for gain-of-function studies, researchers from ...

Therapeutics announced that the first patient has been enrolled in its new Phase 2 clinical trial protocol of stenoparib for the ...

The trial is expected to generate significant clinical data by late summer 2026. Allarity plans to pursue multiple advantaged ...

Immunic, Inc. , a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced participation ...

By balancing supply and demand in real time, the facility not only enhances grid reliability but also supports the ...

This paper delves into the key modulation techniques and demonstrates their simulation using LabVIEW, providing valuable ...

ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of gene expression, announced today its participation in the 2025 ...

Qingyun Pan shares how data-informed choices shaped the development, casting, and visual style of Loser is Winner, a ...

Researchers at Changchun Institute developed binary phase-engraved superpixels, enhancing complex field modulation efficiency ...

Company taps deep technology-to-market experience as it accelerates growth phase Founder Karim Engelmark Cassimjee named chief of innovation Enginzyme AB, a deep-tech company delivering optimized ...